Evaluation of telomerase activity in gingival fibroblasts of cyclosporine-treated patients

被引:1
作者
Biray, C. [1 ]
Nizam, N.
Gunduz, C.
Sonmez, S.
Cavdar, C.
Saglam, F.
Atilla, K.
Camsari, T.
机构
[1] Ege Univ, Sch Med, Dept Med Biol, TR-35100 Izmir, Turkey
关键词
D O I
10.1016/j.transproceed.2007.11.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gingival overgrowth (GO) is a common side effect following administration of cyclosporin A (CsA). Various case reports have shown that squamous cell carcinomas could arise in GO induced by CsA and phenytoin. It is also known that human telomerase activated in about 90% of cancers is mainly composed of hTR, hTERT, and TPI. The aim of this study was to investigate the potential role of telomerase activity in the pathogenesis of CsA-induced GO. Included in the study were 9 patients on CsA: 4 with and 5 without GO. Gingival tissues were obtained during gingivectomy or flap procedures; gingival fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10,000 U/mL penicillin, 10 mg/mL streptomycin, 2 mmol/L L-glutamine, and 10% heat-inactivated fetal bovine serum at 37 degrees C under a humidified 95% air virgule 5% CO2 atmosphere. Quantitative detection of hTERT mRNA was performed with the commercially available LightCycler Telo TAGGG hTERT Quantification Kit using real-time online PCR. The hTERT mRNA expression was positive in one patient, while hTERT mRNA expression was negative in the others. Because results indicated that there may be a relationship between CsA-induced GO and positive telomerase activity, detailed studies should be performed to confirm the present findings.
引用
收藏
页码:184 / 185
页数:2
相关论文
共 50 条
[41]   CARDIAC TRANSPLANTATION - CURRENT RESULTS OF CYCLOSPORINE-TREATED PATIENTS AT THE TEXAS HEART INSTITUTE [J].
PAINVIN, GA ;
OKEREKE, OUJ ;
FRAZIER, OH ;
KAHAN, BD ;
VANBUREN, CT ;
COOLEY, DA .
TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) :223-224
[42]   RENAL-TRANSPLANTATION IN CYCLOSPORINE-TREATED PATIENTS OVER AGE-50 [J].
RIERA, L ;
SERON, D ;
CASTELAO, AM ;
GRINO, JM ;
FRANCO, E ;
BOVER, J ;
VIGUES, L ;
ALSINA, J ;
SERRALLACH, N .
TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) :122-123
[43]   IMMUNOGLOBULIN ABNORMALITIES AND INFECTIOUS LYMPHOPROLIFERATIVE SYNDROME (ILPS) IN CYCLOSPORINE-TREATED TRANSPLANT PATIENTS [J].
TOURAINE, JL ;
ELYAFI, S ;
BOSI, E ;
CHAPUISCELLIER, C ;
RITTER, J ;
BLANC, N ;
DUBERNARD, JM ;
POUTEILNOBLE, C ;
CHEVALLIER, M ;
CREYSSEL, R ;
TRAEGER, J .
TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) :2798-2804
[44]   Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients [J].
Gómez, R ;
Moreno, E ;
Colina, F ;
Loinaz, C ;
Gonzalez-Pinto, I ;
Lumbreras, C ;
Perez-Cerdá, F ;
Castellón, C ;
García, I .
JOURNAL OF HEPATOLOGY, 1998, 28 (01) :150-156
[45]   NATURAL KILLER-CELL ACTIVITY IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS [J].
LEFKOWITZ, M ;
KORNBLUTH, J ;
TOMASZEWSKI, JE ;
JORKASKY, DK .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (02) :121-127
[46]   EVALUATION OF PREDICTORS OF REJECTION AND INFECTION IN CYCLOSPORINE-TREATED SOLID-ORGAN TRANSPLANT RECIPIENTS [J].
GRINDE, S ;
FAGOAGA, O ;
THORPE, R ;
WAHLSTROM, E ;
BAILEY, L ;
NEHLSENCANNARELLA, S .
TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) :2738-2740
[47]   LYMPHADENOPATHY REMINISCENT OF CASTLEMANS SYNDROME IN CYCLOSPORINE-TREATED RATS [J].
BESUSCHIO, SC ;
VILLADON, LE ;
DESANZO, AP .
ANNALES DE PATHOLOGIE, 1990, 10 (5-6) :362-362
[48]   PHARMACODYNAMIC ANALYSES OF CYCLOSPORINE-TREATED RENAL ALLOTRANSPLANT RECIPIENTS [J].
ROGERS, AJ ;
KERMAN, RH ;
KAHAN, BD .
SURGICAL FORUM, 1984, 35 :380-382
[49]   ANALYSIS OF REJECTION IN CYCLOSPORINE-TREATED CARDIAC ALLOGRAFT RECIPIENTS [J].
MACRIS, MP ;
FRAZIER, OH ;
BURSTEIN, T ;
MCALLISTER, HA ;
VANBUREN, CT .
TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) :346-350
[50]   ROLE OF SUPPRESSOR CELLS IN CYCLOSPORINE-TREATED ALLOGRAFT RECIPIENTS [J].
KERMAN, RH ;
FLECHNER, SM ;
VANBUREN, CT ;
LORBER, MI ;
KAHAN, BD .
TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) :1580-1583